Uterus Showing Multiple Adenomyomas (Diffuse Adenomyosis)

Description

Uterine wall anatomy is presented in an internal cutaway view that exposes the endometrial cavity and the surrounding myometrium, with multiple adenomyomas scattered through the muscle layer in a diffuse adenomyosis pattern. Irregular, ill-defined nodules extend from the endometrium into the inner and mid myometrium, blurring the usual junctional zone and creating a patchy, thickened appearance rather than a single circumscribed mass. The serosal contour is preserved externally, while the bulk of pathology sits deep to the perimetrium and encroaches toward the cavity. Orientation favors inspection of the cavity-to-serosa depth, letting you judge how far the ectopic endometrial glands and stroma track into the uterine musculature. Diffuse adenomyosis matters because it produces heavy menstrual bleeding and dysmenorrhea through myometrial hypertrophy and disordered contractility, and it can mimic leiomyomas clinically while behaving differently at imaging and in the operating room. Unlike a typical fibroid, adenomyomas lack a true capsule and interdigitate with myometrium, which explains why focal excision often leaves residual disease and why hysterectomy remains definitive for many symptomatic patients who have completed childbearing. The internal perspective supports teaching of MRI and ultrasound correlation, where a thickened junctional zone, heterogeneous myometrium, and small cystic spaces are classic clues. It also reinforces the common co-occurrence with endometriosis and the impact on fertility workups. Use this illustration in gynecologic pathology lectures, reproductive endocrinology modules, and surgical counseling materials that contrast adenomyosis with leiomyoma in terms of margins, resectability, and symptom profile. It also fits well in patient-facing diagrams for abnormal uterine bleeding clinics when you need a single image that explains diffuse myometrial involvement without implying a discrete tumor. Anatomical accuracy verified by SciePro's Medical Advisory Board.